Sangtae Park, M.D., M.P.H. is the Chief of Minimally Invasive Urology (Single Port Surgery) and is the Urologic Expert in the Minimally Invasive Surgical Training and Innovation Lab (MISTI) in the Department of Surgery at NorthShore University HealthSystem. His research and clinical interests include single port laparoscopic surgery, natural orifice (NOTES) urological surgery and robotic urological surgery. He uses these modalities to treat kidney, bladder, prostate cancers and benign conditions and is actively pursuing research to improve patient outcomes and surgical quality. Dr. Park is widely published in the medical literature, and serves on the review committee and editorial board of several leading urology journals. He has held professorships at distinguished medical centers such as the University of Washington, University of Chicago and served as a visiting professor at University of California, San Francisco, the Korean Urological Association and Interlaken, Switzerland.
Best Poster - UCSF Joint Brain, Breast and Prostate Cancer SPORE meeting, 2004
Guest Speaker - International Urology Forum, Interlaken, Switzerland, 2007
Best Poster - Engineering and Urology Society meeting, Chicago, IL, 2009
Co-Chair, 2009 Korean World Urologic Congress, 2009
2007 Plenary Session Speaker, 2007 Korean Urological Association National Meeting, 2007
1. Yoon WJ, Brown, MA, Reinhall PG, Park S, Seibel EJ, Active Steering of a Custom Laser Scanning Cystoscope for Automated Bladder Surveillance. IEEE/ASME Transcations on Mechatronics, Feb 2010.
2. Yoon WJ, Park S, Reinhall PG, Seibel EJ, Development of an automated steering mechanism for bladder urothelium surveillance. American Society of Mechanical Engineering Journal of Medical Devices, 2009 Mar: 3(1):1-10.
3. Long L, Park S. Differences in patterns of care: reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty. J. Endourol. 2009 Mar; 23(3):421-6
4. Zeltser I, Dugi D, Gupta A, Park S, Kabbani W, Cadeddu J. Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle? BJU Int. 2008 Sep;102(8):1005-7.
5. Zeltser IS, Gupta A, Bensalah K, Kabbani W, Jenkins A, Park S, Pearle MS, Cadeddu J. Focal radiofrequency coagulation-assisted laparoscopic partial nephrectomy: a novel nonischemic technique. J. Endourol. 2008 Jun;22(6):1269-73.
6. Tuncel A, Lucas S, Bensalah K, Zeltser IS, Jenkins A, Saeedi O, Park S, Cadeddu JA. A randomized comparison of conventional vs articulating laparoscopic needle-drivers for performing standardized suturing tasks by laparoscopy-naïve subjects. BJU Int. 2008 Mar;101(6):727-30.
7. Zeltser IS, Moonat S, Park S, Anderson JK, Cadeddu JA. Intermediate-term prospective results of radiofrequency-assisted laparoscopic partial nephrectomy: a non-ischaemic coagulative technique. BJU Int. 2008 Jan;101(1):36-8.
8. Park S, Pearle MS, Cadeddu JA, Lotan Y. Laparoscopic and open partial nephrectomy: cost comparison with analysis of individual parameters. J. Endourol. 2007 Dec;21(12):1449-54.
9. Shariat SF, Park S, Trinh QD, Roehrborn CG, Slawin KM, Karakiewicz PI. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. J Urol. 2007 Oct;178(4):1229-37.
10. Long LO, Park S. Update on nephrolithiasis management. Minerva Urol Nefrol. 2007 Sep;59(3):317-25.
11. Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin North Am. 2007 Aug;34(3):323-34.
12. Stern JM, Stanfield J, Lotan Y, Park S, Hsieh JT, Cadeddu JA. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol. 2007 Aug;21(8):939-43.
13. Stern JM, Svatek R, Park S., Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007 Aug;100(2):287-90.
14. Park, S., Cadeddu, JA. Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 2007 Jul;14(3):205-10.
15. Park S., Medical Management of urinary stone disease. Expert Opin Pharmacother. 2007 Jun;8(8): 1117-25.
16. Stern JM, Park S., Anderson JK, Landman J, Pearle M, Cadeddu JA. Functional assessment of crossing vessels as etiology of ureteropelvic junction obstruction. Urology. 2007 Jun;69(6):1022-4.
17. Duchene DA, Winfield HN, Cadeddu JA, Clayman RV, Gomella LG, Kavoussi LR, Mikhail AA, Park S., Permpongkosol S, Shalhav AL. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology. 2007 Jun;69(6):1017-21.
18. Park S., Bergs R., Eberhart R., Baker L., Fernandez R., Cadeddu J.A. Trocar-less laparoscopy: Magnetic positioning of intra-abdominal camera and retractor. Annals of Surgery. 2007 March; 245(3):379-384.
19. Park S., Wians, F.H. and Cadeddu, J.A. Spurious prostate specific antigen (PSA) recurrence after radical prostatectomy: Interference by human anti-mouse heterophile antibodies. Int J Urol. 2007 Mar;14(3):251-253.
20. Stern, J.M., Yiee, J., Park S. Safety and efficacy of ureteral access sheaths. J Endourol. 2007 Feb;21(2):119-23.
21. Shariat SF, Roehrborn CG, Park S, McConnell JD, Alam N, Wheeler TM, Slawin KM. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol. 2007 Feb 1;25(4):349-55.
22. Park S., Cadeddu J.A., Shingleton W.B. Oncologic Outcomes for Ablative Therapy for Kidney Cancer. Curr Urol Rep. 2007 Jan;8(1):31-7.
23. Park S., Jaffer O., Lotan Y., Saboorian, H., Roehrborn C.G., Cadeddu J.A. Contemporary laparoscopic and open radical retropubic prostatectomy: pathologic outcomes and Kattan postoperative nomograms are equivalent. Urology. 2007 Jan;69(1):118-22.
24. Park S., Strup S., Saboorian H., Cadeddu J.A. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens. Urology, 2006 Nov; 68(5):964-7.
25. Stern J.M., Anderson J.K., Lotan Y., Park S., Cadeddu J.A.. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol. 2006 Nov; 176(5):1969-72.
Sangtae Park, MD, MPH's contact info
Address & contact info:
1959 NE Pacific
Glencoe, IL 60022
Every effort has been made to ensure the accuracy of the information in this directory. However some
changes may occur between updates. Please check with your provider to ensure that he or she
participates in your health plan.
THURSDAY, April 17, 2014 (HealthDay News) -- Doctors often recommend no treatment at all when a man is diagnosed with prostate cancer, opting instead to keep a close eye on the slow-growing tumor and acting only when it becomes aggressive.
But a new, long-term European study says this str...Full Article
FRIDAY, Feb. 21, 2014 (HealthDay News) -- The tools of war have changed. With the increased use of powerful explosive devices, men and women patrolling on foot in bomb-laced areas of combat are increasingly suffering traumatic injuries to the groin and genitals, experts say.
MONDAY, Feb. 17, 2014 (HealthDay News) -- Following the recent announcement from the U.S. Food and Drug Administration about the potential hazards of using testosterone supplements in older men, another group of experts is raising concerns about the popular treatments.
TUESDAY, Jan. 28, 2014 (HealthDay News) -- A new hormone therapy drug for men with prostate cancer may increase survival a bit and delay progression of the disease in men who have advanced prostate cancer that has been resistant to standard hormonal therapies, a new study suggests.
MONDAY, Jan. 20, 2014 (HealthDay News) -- A link may exist between the sleep hormone melatonin and prostate cancer, according to a new study. But experts say it's too early for men to start popping melatonin supplements to help prevent the disease.
WEDNESDAY, Jan. 1, 2014 (HealthDay News) -- When men are young, testosterone tends to get a bad rap, often blamed for aggressive and overly competitive behavior. But as men get older, the bad rap continues, though for a different reason.
In older men, it's low testosterone that has captur...Full Article
Sharecare News posted a story about Infectious Disease:
WEDNESDAY, Dec. 18, 2013 (HealthDay News) -- Should people in danger of contracting HIV because they have risky sex take a pill to prevent infection, or will the medication encourage them to take even more sexual risks?
After years of debate on this question, a new international study sug...Full Article
TUESDAY, Dec. 17, 2013 (HealthDay News) -- In rare cases, Ritalin and some other drugs used to treat attention-deficit/hyperactivity disorder (ADHD) can cause long-lasting and sometimes painful erections, the U.S. Food and Drug Administration said Tuesday.